Glenmark Pharmaceuticals gains on the bourses

06 Mar 2018 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 564.25, up by 13.55 points or 2.46% from its previous closing of Rs. 550.70 on the BSE.

The scrip opened at Rs. 555.00 and has touched a high and low of Rs. 566.20 and Rs. 554.00 respectively. So far 34839 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 930.00 on 11-May-2017 and a 52 week low of Rs. 517.40 on 19-Feb-2018.

Last one week high and low of the scrip stood at Rs. 553.00 and Rs. 537.50 respectively. The current market cap of the company is Rs. 15801.42 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 37.07% and 16.40% respectively.

Glenmark Pharmaceuticals has presented new data on Ryaltris, an investigational fixed-dose combination nasal spray for Seasonal Allergic Rhinitis (SAR), at the AAAAI/WAO Joint Congress in Orlando, Florida.

New data was studied on more than 2,400 patients to 14 days of twice-daily treatment with Ryaltris or placebo. Ryaltris (mometasone furoate (25 mcg) and olopatadine hydrochloride (665 mcg)), formerly GSP 301 Nasal Spray, is Glenmark’s leading respiratory candidate with a New Drug Application filing anticipated in the first half of 2018.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×